Government Relations: Speak With One Voice

Published in Government Relations on April 18, 2024

Mike “Ike” IsaacsonThis post was originally featured in HME News.

Q. How do we enhance our message?

A. When we speak together, we improve the health care landscape. We demonstrate that we are a trustworthy and dependable source of information and expertise, and that we represent a large and diverse group of stakeholders who all care deeply about the DMEPOS industry and those we serve. This collective voice pushes back on any negative or false claims that may come from other interests or groups. 

We increase the awareness and recognition of the DMEPOS industry and its value, as we can reach more people and media, and create a stronger and more lasting impression. We can enhance coordination and cooperation among the industry, as we can share our data, resources, strategies and best practices, and avoid any confusion or inconsistency in our efforts. This leads to a stronger sense of community and commitment within the industry and serves to motivate us to keep working and overcoming any challenges.   

However, speaking together is not easy, and it requires careful planning and management. We may face some challenges, such as: finding a common goal and a shared vision among ourselves; respecting and addressing the diversity and differences in the industry; balancing the interests and needs of our colleagues; ensuring effective communication and feedback; and resolving any conflicts or disputes that may arise. 

Therefore, it is urgent, now more than ever, that we join together through state associations and national membership and advocacy groups such as VGM, NCART, AAHomecare and others. Speaking together is the key factor for improving our advocacy success: It increases our credibility, awareness and coordination. 

In 2024, the DMEPOS industry had a significant role in the debates in Washington, D.C. To ensure that we sustain that momentum, even in the face of setbacks, we must show a unified front, speak with a unified voice, and together be champions of change. 

Mike “Ike” Isaacson is senior vice president of government relations at VGM & Associates. Reach him at Michael.Isaacson@vgm.com.


TAGS

  1. advocacy
  2. dmepos
  3. legislation
  4. vgm
  5. vgm government

From Our Experts

Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse thumbnail Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse This week, the Trump administration, through the Centers for Medicare & Medicaid Services (CMS), announced a significant deferral of federal Medicaid matching funds to Minnesota alongside the release of a new Request for Information (RFI) tied to the administration's Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. These actions along with the changes to DMEPOS accreditation and enrollment signal the administration's aggressive posture on Medicaid and Medicare... Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium thumbnail Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium In a press release published on the CMS website Feb. 25, 2026, it was announced that CMS will implement a six-month moratorium on new enrollments for DMEPOS suppliers. VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message. Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases thumbnail Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases The DME Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) change for seat elevation use on group 2 non-complex power wheelchair bases (K0830, K0831 and K0108 on group 2 non-complex HD bases). John Quinlan Named 2026 Van G. Miller Homecare Champion thumbnail John Quinlan Named 2026 Van G. Miller Homecare Champion AAHomecare announced earlier this week that John Quinlan of Quinlan's Pharmacy in New York has been selected as the recipient of this year's Van G. Miller Award. John has been a valued VGM member for many years, and his leadership within the DMEPOS community has made a meaningful impact on patients, providers, and the industry as a whole. His commitment to quality care, patient access, and industry advocacy consistently sets him apart. Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program thumbnail Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program Many of you have already contacted your legislators in support of key DME legislation, including the DMEPOS Relief Act, the Choices for Increased Mobility Act, and the Supplemental Oxygen Access Reform (SOAR) Act. We now have another important issue to bring to your attention. CMS Revises Nebulizer Policy and ABN Form thumbnail CMS Revises Nebulizer Policy and ABN Form CMS has issued an update regarding revisions to the CMS Nebulizer Policy Article and guidance on the Advanced Beneficiary Notice of Noncoverage (ABN) Form. For dates of service on or after Feb. 1, 2026, suppliers must include the KX, GA, or GZ modifier to claims for the following nebulizer items: CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 thumbnail CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 Earlier this week, Congress extended Medicare telehealth flexibilities through Dec, 31, 2027, as part of the newly signed federal funding bill. In response, CMS has released updated Telehealth Frequently Asked Questions (FAQ) to provide clarity on what the extension means for both patients and providers.